• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在沙特国家免疫规划引入轮状病毒疫苗后,轮状病毒仍是住院儿科患者腹泻疾病的主要病因吗?

Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?

作者信息

Hegazi Moustafa Abdelaal, Sayed Mohamed Hesham, Sindi Haifa Hasan, Bekhit Osama Elsayed, El-Deek Basem Salama, Alshoudri Faisal M Yaqoub, Noorelahi Amroo Khaled

机构信息

Department of Pediatrics, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia Department of Pediatrics, Mansoura University Children's Hospital, Mansoura, Egypt Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt Department of Pediatrics, Maternity and Children Hospital (Al-Mossadia), Jeddah, Saudi Arabia Department of Pediatrics, Faculty of Medicine, Fayoum University, Egypt Department of Pediatrics, Hai Al-Jameah Hospital, Jeddah, Saudi Arabia Department of Community Medicine and Public Health, Mansoura Faculty of Medicine, Mansoura, Egypt Department of Community Medicine and Public Health, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

Medicine (Baltimore). 2017 Apr;96(15):e6574. doi: 10.1097/MD.0000000000006574.

DOI:10.1097/MD.0000000000006574
PMID:28403085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5403082/
Abstract

Previous studies in Jeddah, western Saudi Arabia, showed rotavirus (RV) prevalence around 40% in pediatric inpatients with gastroenteritis (GE) with a maximum level during cooler months. Currently, there are no data on impact of rotavirus vaccine (RVV) on RV-GE in Saudi Arabia. Therefore, this study was conducted to assess impact of RVV on incidence and severity of RV-GE in hospitalized pediatric patients; 3 years after introduction of RVV in Saudi immunization program (SIP) in January, 2013.This cross-sectional observational study included GE cases under 5 years of age admitted to 2 tertiary hospitals, in Jeddah, from October to December, 2015. All included GE-cases had RV antigen detection in stool by immunochromatographic assay, complete data collection including RVV status and severity assessment (Vesikari score) in initial admission.During study period, a total of 359 GE cases in children under 5 years of age were hospitalized with 14 (3.9%) RV-GE confirmed cases. Mean age of RV-GE patients was 13.10 ± 5.70 months. All RV cases had severe GE and 1 case received RVV. Among other 345 GE cases, 35.7% did not receive RVV and 46.1% had severe GE. Severe GE (Vesikari score > 11) was more significantly identified among RV-GE cases than in other all-cause GE (P < .001). During same period of this study in 2012, 369 RV-GE out of 1193 total GE cases (31%) were hospitalized at 2 hospitals, so, number of hospitalized pediatric patients for all-cause and RV-GE in children under 5 years of age decreased significantly in 2015 RV season (compared to 2015 RV season, odds ratio for RV-GE in 2012: 11.04, 95% CI: 6.38-19.09).Logistic regression analysis of variables of this cross-sectional, hospital-based study in Jeddah, Saudi Arabia, 3 years after introduction of RVV in SIP, showed that among the studied variables, RVV was associated with remarkable reduction of hazard of all-cause and RV-GE in vaccinated and even in unvaccinated children under 5 years of age possibly by RVV herd effect. However, RV was still associated with severe GE-related hospitalizations in unvaccinated children against RV who were younger than 2 years and particularly in the 1st year of life, indicating need for more optimum rate of RVV coverage. Hopefully, further improvement in RVV coverage rate may make RV-GE a disease of the past in Saudi children.

摘要

先前在沙特阿拉伯西部吉达开展的研究表明,在患有肠胃炎(GE)的儿科住院患者中,轮状病毒(RV)感染率约为40%,在较凉爽的月份达到最高水平。目前,尚无关于轮状病毒疫苗(RVV)对沙特阿拉伯RV-GE影响的数据。因此,本研究旨在评估RVV对住院儿科患者RV-GE发病率和严重程度的影响;这是在2013年1月沙特免疫计划(SIP)引入RVV三年后进行的。这项横断面观察性研究纳入了2015年10月至12月在吉达两家三级医院住院的5岁以下GE病例。所有纳入的GE病例均通过免疫层析法检测粪便中的RV抗原,在初次入院时完成包括RVV状态和严重程度评估(韦西卡里评分)在内的数据收集。在研究期间,共有359例5岁以下儿童因GE住院,其中14例(3.9%)确诊为RV-GE病例。RV-GE患者的平均年龄为13.10±5.70个月。所有RV病例均患有严重GE,1例接受了RVV。在其他345例GE病例中,35.7%未接种RVV,46.1%患有严重GE。与其他所有病因的GE相比,RV-GE病例中严重GE(韦西卡里评分>11)的确诊率更高(P< .001)。在本研究的同一时期,2012年两家医院共1193例GE病例中有369例(31%)因RV-GE住院,因此,2015年RV流行季5岁以下儿童因各种病因和RV-GE住院的患儿数量显著减少(与2012年RV流行季相比,2012年RV-GE的优势比:11.04,95%CI:6.38-19.09)。在SIP引入RVV三年后,对沙特阿拉伯吉达这项基于医院的横断面研究的变量进行逻辑回归分析表明,在研究的变量中,RVV与接种疫苗以及未接种疫苗的5岁以下儿童中各种病因和RV-GE风险的显著降低相关,这可能是由于RVV的群体效应。然而,对于未接种RV疫苗的2岁以下儿童,尤其是在生命的第一年,RV仍与严重GE相关住院有关,这表明需要提高RVV的覆盖率。有望进一步提高RVV覆盖率,使RV-GE在沙特儿童中成为过去式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2720/5403082/9203f508160b/medi-96-e6574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2720/5403082/9203f508160b/medi-96-e6574-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2720/5403082/9203f508160b/medi-96-e6574-g002.jpg

相似文献

1
Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?在沙特国家免疫规划引入轮状病毒疫苗后,轮状病毒仍是住院儿科患者腹泻疾病的主要病因吗?
Medicine (Baltimore). 2017 Apr;96(15):e6574. doi: 10.1097/MD.0000000000006574.
2
The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.也门引入轮状病毒疫苗前后全因性和轮状病毒急性胃肠炎的流行病学及轮状病毒流行毒株特征:基于医院监测数据的分析
BMC Infect Dis. 2015 Oct 13;15:418. doi: 10.1186/s12879-015-1165-8.
3
Rotavirus Gastroenteritis Infection Among Children Vaccinated and Unvaccinated With Rotavirus Vaccine in Southern China: A Population-Based Assessment.轮状病毒胃肠炎在接种和未接种轮状病毒疫苗的中国南方儿童中的感染:一项基于人群的评估。
JAMA Netw Open. 2018 Aug 3;1(4):e181382. doi: 10.1001/jamanetworkopen.2018.1382.
4
Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar.轮状病毒疫苗对塞内加尔 5 岁以下儿童急性肠胃炎的影响:达喀尔阿尔贝·罗耶儿童医院哨点经验。
Vaccine. 2018 Nov 12;36(47):7192-7197. doi: 10.1016/j.vaccine.2017.10.061. Epub 2017 Nov 20.
5
Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.2006年至2011年美国轮状病毒疫苗接种对婴儿轮状病毒相关医疗接触减少的群体免疫证据及持续影响。
Pediatr Infect Dis J. 2015 Jun;34(6):615-20. doi: 10.1097/INF.0000000000000702.
6
Early impact of rotavirus vaccination in children less than five years of age in Mozambique.莫桑比克五岁以下儿童中轮状病毒疫苗接种的早期影响。
Vaccine. 2018 Nov 12;36(47):7205-7209. doi: 10.1016/j.vaccine.2017.10.060. Epub 2017 Nov 8.
7
Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.在芬兰的 4 年中,罗特律®(Rotarix®)在轮状病毒相关胃肠炎住院治疗方面保持了高度有效性。
J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):317-323. doi: 10.1093/jpids/piw061.
8
Acute gastroenteritis hospitalizations after implementation of universal mass vaccination against rotavirus.实施轮状病毒普遍大规模疫苗接种后的急性肠胃炎住院情况。
Vaccine. 2020 Mar 17;38(13):2879-2886. doi: 10.1016/j.vaccine.2020.01.098. Epub 2020 Feb 14.
9
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.亚洲及太平洋地区轮状病毒疫苗使用情况综述:挑战与未来展望。
Expert Rev Vaccines. 2021 Dec;20(12):1499-1514. doi: 10.1080/14760584.2020.1853532. Epub 2021 Apr 20.
10
Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland.斯威士兰因腹泻住院的 5 岁以下儿童中轮状病毒疫苗的早期影响
Vaccine. 2018 Nov 12;36(47):7210-7214. doi: 10.1016/j.vaccine.2017.07.072. Epub 2017 Aug 1.

引用本文的文献

1
Molecular Epidemiology and Surveillance of Human Adenovirus and Rotavirus A Associated Gastroenteritis in Riyadh, Saudi Arabia.沙特阿拉伯利雅得人类腺病毒和A组轮状病毒相关肠胃炎的分子流行病学与监测
Trop Med Infect Dis. 2023 May 15;8(5):279. doi: 10.3390/tropicalmed8050279.
2
The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji.轮状病毒疫苗在斐济全国推广五年后对腹泻的影响。
Lancet Reg Health West Pac. 2020 Nov 25;6:100053. doi: 10.1016/j.lanwpc.2020.100053. eCollection 2021 Jan.
3
Emergence of equine-like G3 strains as the dominant rotavirus among children under five with diarrhea in Sabah, Malaysia  during 2018-2019.

本文引用的文献

1
A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years.轮状病毒疫苗对5岁以下儿童腹泻结局影响的系统评价
Pediatr Infect Dis J. 2016 Sep;35(9):992-8. doi: 10.1097/INF.0000000000001232.
2
Epidemiology of rotavirus A diarrhea in Chókwè, Southern Mozambique, from February to September, 2011.2011 年 2 月至 9 月,莫桑比克南部乔奎腹泻轮状病毒 A 的流行病学。
J Med Virol. 2016 Oct;88(10):1751-8. doi: 10.1002/jmv.24531. Epub 2016 Mar 29.
3
Success of rotavirus vaccination in Africa: good news and remaining questions.
2018-2019 年期间,马来西亚沙巴州五岁以下腹泻儿童中,马科病毒样 G3 株成为主要轮状病毒。
PLoS One. 2021 Jul 28;16(7):e0254784. doi: 10.1371/journal.pone.0254784. eCollection 2021.
4
Erratum: Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?: Erratum.勘误:在沙特国家免疫规划引入轮状病毒疫苗后,轮状病毒仍是住院儿科患者腹泻疾病的主要病因吗?:勘误。
Medicine (Baltimore). 2017 Jun 16;96(24):e7314. doi: 10.1097/MD.0000000000007314. eCollection 2017 Jun.
5
Systematic review of the rotavirus infection burden in the WHO-EMRO region.世界卫生组织东地中海区域轮状病毒感染负担的系统评价
Hum Vaccin Immunother. 2019;15(11):2754-2768. doi: 10.1080/21645515.2019.1603984. Epub 2019 May 17.
6
Reduction of hospitalizations with diarrhea among children aged 0-5 years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine.在毛里塔尼亚努瓦克肖特,引入轮状病毒疫苗后,0-5 岁儿童腹泻住院人数减少。
Vaccine. 2019 Mar 7;37(11):1407-1411. doi: 10.1016/j.vaccine.2019.01.078. Epub 2019 Feb 11.
非洲轮状病毒疫苗接种的成功:好消息与遗留问题
Lancet Glob Health. 2016 Feb;4(2):e76-7. doi: 10.1016/S2214-109X(15)00318-6.
4
Etiology of diarrhea among children under the age five in China: Results from a five-year surveillance.中国五岁以下儿童腹泻病因:五年监测结果
J Infect. 2015 Jul;71(1):19-27. doi: 10.1016/j.jinf.2015.03.001. Epub 2015 Mar 6.
5
Burden and genotyping of rotavirus disease in the United Arab Emirates: a multicenter hospital-based surveillance.阿联酋轮状病毒疾病的负担和基因分型:一项多中心基于医院的监测。
Hum Vaccin Immunother. 2014;10(8):2284-9. doi: 10.4161/hv.29386.
6
Evaluation of an immunochromatographic assay for the rapid and simultaneous detection of rotavirus and adenovirus in stool samples.评估一种用于快速同时检测粪便样本中轮状病毒和腺病毒的免疫层析检测法。
Ann Lab Med. 2014 May;34(3):216-22. doi: 10.3343/alm.2014.34.3.216. Epub 2014 Apr 8.
7
Rotavirus infection among Sudanese children younger than 5 years of age: a cross sectional hospital-based study.苏丹5岁以下儿童轮状病毒感染情况:一项基于医院的横断面研究。
Pan Afr Med J. 2013 Nov 10;16:88. doi: 10.11604/pamj.2013.16.88.2519. eCollection 2013.
8
Risk factors of rotavirus diarrhea in hospitalized children in Sanglah Hospital, Denpasar: a prospective cohort study.登巴萨桑格拉医院住院儿童轮状病毒腹泻的危险因素:一项前瞻性队列研究。
BMC Gastroenterol. 2014 Mar 26;14:54. doi: 10.1186/1471-230X-14-54.
9
Rotavirus vaccines: successes and challenges.轮状病毒疫苗:成功与挑战。
J Infect. 2014 Jan;68 Suppl 1:S9-18. doi: 10.1016/j.jinf.2013.09.010. Epub 2013 Oct 22.
10
The burden of Rotavirus gastroenteritis among hospitalized pediatric patients in a tertiary referral hospital in Jeddah.吉达一家三级转诊医院中住院儿科患者的轮状病毒肠胃炎负担。
Ann Saudi Med. 2013 May-Jun;33(3):241-6. doi: 10.5144/0256-4947.2013.241.